Recent Quotes

My Watchlist

Indicators

News

Currencies

International

Treasuries

Kazia Therapeutics Ltd ADR (NQ: KZIA )

5.840 +0.240 (+4.29%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 23, 2022 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	10,200
Open	5.760
Bid (Size)	5.720 (5)
Ask (Size)	9.570 (1)
Prev. Close	5.600
Today's Range	5.680 - 6.970
52wk Range	5.010 - 12.28
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Kazia Therapeutics Concludes Mid-Stage Paxalisib Study In Brain Cancer

April 21, 2022

Kazia Therapeutics Limited (NASDAQ: KZIA) has completed a Phase 2 study of paxalisib in glioblastoma.

Via Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

April 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Performance

YTD	-31.78%	-31.78%
1 Month	-21.40%	-21.40%
3 Month	-18.18%	-18.18%
6 Month	-46.32%	-46.32%
1 Year	-35.89%	-35.89%

More News

Kazia TherapeuticsTrust (KZIA): Several Upcoming Catalysts

March 30, 2022

From Edison Investment Research Limited

Via AccessWire

A Peek Into The Markets: US Stock Futures Gain After S&P 500 Hits Record High

December 13, 2021

Via Benzinga

60 Biggest Movers From Yesterday

December 07, 2021

Via Benzinga

Kazia Unveils Final Data From Mid-Stage Paxalisib Data In Newly Diagnosed Glioblastoma Patients

December 03, 2021

Via Benzinga

A Peek Into The Markets: US Stock Futures Higher Ahead Of Tyson Foods Earnings

November 15, 2021

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021

October 14, 2021

Via Benzinga

Kazia TherapeuticsTrust (KZIA): Multiple Paxalisib Data Points Expected in Q4

October 14, 2021

From Edison Investment Research Limited

Via AccessWire

Kazia Therapeutics (KZIA): New asset to target tumor lymphangiogenesis

April 20, 2021

From Edison Investment Research Limited

Via AccessWire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

April 14, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2022 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.PLEASE NOTE: This website contains hyperlinks (or “links”) to other websites that are not associated with this site. Such unassociated websites may contain links to other unassociated sites as well. These links are provided as a convenience to you and to assist you in your search for information. We make no endorsement, express or implied, about any of these linked sites, are not responsible for materials posted or activities that occur on such linked sites, and do not review (1) content or advertisements posted on or (2) activities occurring on these linked sites. If you decide to link to any unassociated website, it is at your own risk. Because we are not associated with these linked websites, you should direct any concerns or problems you might have with any such site to that site’s administrator or webmaster.” (these links can be found on the Market Action section and the Market News section)

Kazia Therapeutics Ltd ADR (NQ: KZIA )

Price and Volume

Top News

Performance

More News

Market Action

MARKET NEWS